DANIEL D KARP to Patient Selection
This is a "connection" page, showing publications DANIEL D KARP has written about Patient Selection.
Connection Strength
0.084
-
The changing face of phase 1 cancer clinical trials: new challenges in study requirements. Cancer. 2009 Apr 15; 115(8):1592-7.
Score: 0.047
-
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4).
Score: 0.027
-
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005 Jan 19; 97(2):94-102.
Score: 0.009